Clinical Trial Update: A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

A randomized, open-label, single-dosing, 2x2 crossover Phase 1 study comparing safety and pharmacokinetics of BR-TND Tablet (tenofovir disoproxil) with Viread T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Hepatitis

Drugs mentioned

• BR-TND Tablet (tenofovir disoproxil)
• Viread Tablet (tenofovir disoproxil fumarate)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hepatitis | Phase 1 | Status: COMPLETED